Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

Second cancers are far deadlier in younger people than older adults

Second cancers are far deadlier in younger people than older adults

Researcher aims to eliminate chemotherapy-resistant ovarian tumors using virus treatment

Researcher aims to eliminate chemotherapy-resistant ovarian tumors using virus treatment

NCCN Radiation Therapy Compendium adds nine new clinical practice guidelines in oncology

NCCN Radiation Therapy Compendium adds nine new clinical practice guidelines in oncology

Hypertension linked to better outcomes for subset of ovarian cancer patients

Hypertension linked to better outcomes for subset of ovarian cancer patients

Research finds diagnostic tests to be less accurate for children with impaired kidney function

Research finds diagnostic tests to be less accurate for children with impaired kidney function

Research finding could offer new way to fight deadly pancreatic cancer

Research finding could offer new way to fight deadly pancreatic cancer

MIT engineers develop more sensitive approach to reveal ovarian tumors

MIT engineers develop more sensitive approach to reveal ovarian tumors

Genomic analysis technologies: past, present and future

Genomic analysis technologies: past, present and future

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Researchers identify biomarker for likely aggressive, early-stage breast cancers

Researchers identify biomarker for likely aggressive, early-stage breast cancers

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Researchers explore factors that influence patient's intent to get colorectal cancer screening

Researchers explore factors that influence patient's intent to get colorectal cancer screening

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

Study finds steady increase in BRCA testing among low-risk women

Study finds steady increase in BRCA testing among low-risk women

Researchers develop new method that uses gene editing to find cancer's weak spots

Researchers develop new method that uses gene editing to find cancer's weak spots

Studies question use of readmission rate as metric in surgeries for ovarian cancer patients

Studies question use of readmission rate as metric in surgeries for ovarian cancer patients